Corticobasal Degeneration Clinical Trials
2 recruiting trials for Corticobasal Degeneration. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Corticobasal Degeneration clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Beth Israel Deaconess Medical Center (1), New York Stem Cell Foundation Research Institute (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Anti-Parkinson medication (drug, 1 trial), followed by Deep Brain Stimulation, Biological Sample Collection.
Track Corticobasal Degeneration trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Gait Analysis in Neurological Disease
The purpose of this study is to investigate whether speed-dependent measures of gait can be identified in patients with neurological conditions that affect gait, particularly in...
NYSCF Scientific Discovery Biobank
The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Corticobasal Degeneration, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Corticobasal Degeneration, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Corticobasal Degeneration, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.